Notable healthcare headlines for the week: J&J, Masimo and Bayer in focus
Wall Street's major indices closed higher, with the S&P 500 Health Care Index declining 0.35%. Notable healthcare news includes Johnson & Johnson exploring a $20B sale of its orthopedics business, Bayer facing skepticism over a $7.25B Roundup settlement, and Masimo agreeing to be acquired by Danaher for $180 per share, a 38% premium. Medtronic's stock fell over 3% after reaffirming its earnings outlook amid tariff impacts. Ongoing pharmaceutical tariffs remain a concern despite a recent Supreme Court ruling.
Source: businessinsider The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments